LanssonPharm Secures Series A Funding to Accelerate CNS Drug Development
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...